How has Collegium Pharmaceutical, Inc.'s net investment in lease changed year-over-year?

Collegium Pharmaceutical, Inc.'s net investment in lease decreased by 28.3% year-over-year, from $5.55M to $3.98M.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s net investment in lease has grown at a -13.0% compound annual growth rate (CAGR), from $8.39M to $4.19M.

Collegium Pharmaceutical, Inc. COLL Net Investment in Lease

Net Investment in Lease at other companies

Indivior Pharmaceuticals, Inc. INDV

——

Catalyst PharmaceuticalCPRX

——

Avanos MedicalAVNS

——

Pacira BioSciences, Inc.PCRX

——

Supernus PharmaceuticalsSUPN

——

Theravance BiopharmaTBPH

——

Segments

By geography

See full

Stoughton, Massachusetts$4.17M—

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+20.4%

Enterprise value$869.67M+2.5%

P/E15.4×-6.4×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s net investment in lease?: Collegium Pharmaceutical, Inc. (COLL) reported net investment in lease of $3.98M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s net investment in lease changed year-over-year?: Collegium Pharmaceutical, Inc.'s net investment in lease decreased by 28.3% year-over-year, from $5.55M to $3.98M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s net investment in lease has grown at a -13.0% compound annual growth rate (CAGR), from $8.39M to $4.19M.